Literature DB >> 18221378

Regulation of psychostimulant-induced signaling and gene expression in the striatum.

Jacqueline F McGinty1, Xiangdang D Shi, Marek Schwendt, Alicia Saylor, Shigenobu Toda.   

Abstract

Amphetamine (AMPH) and cocaine are indirect dopamine agonists that activate multiple signaling cascades in the striatum. Each cascade has a different subcellular location and duration of action that depend on the strength of the drug stimulus. In addition to activating D1 dopamine-Gs-coupled-protein kinase A signaling, acute psychostimulant administration activates extracellular-regulated kinase transiently in striatal cells; conversely, inhibition of extracellular-regulated kinase phosphorylation decreases the ability of psychostimulants to elevate locomotor behavior and opioid peptide gene expression. Moreover, a drug challenge in rats with a drug history augments and prolongs striatal extracellular-regulated kinase phosphorylation, possibly contributing to behavioral sensitization. In contrast, AMPH activates phosphoinositide-3 kinase substrates, like protein kinase B/Akt, only in the nuclei of striatal cells but this transient increase induced by AMPH is followed by a delayed decrease in protein kinase B/Akt phosphorylation whether or not the rats have a drug history, suggesting that the phosphoinositide-3 kinase pathway is not essential for AMPH-induced behavioral sensitization. Chronic AMPH or cocaine also alters the regulation of inhibitory G protein-coupled receptors in the striatum, as evident by a prolonged decrease in the level of regulator of G protein signaling 4 after non-contingent or contingent (self-administered) drug exposure. This decrease is exacerbated in behaviorally sensitized rats and reversed by re-exposure to a cocaine-paired environment. A decrease in regulator of G protein signaling 4 levels may weaken its interactions with metabotropic glutamate receptor 5, Galphaq, and phospholipase C beta that may enhance drug-induced signaling. Alteration of these protein-protein interactions suggests that the striatum responds to psychostimulants with a complex molecular repertoire that both modulates psychomotor effects and leads to long-term neuroadaptations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18221378      PMCID: PMC3120109          DOI: 10.1111/j.1471-4159.2008.05240.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  88 in total

Review 1.  Regulators of G-protein signalling: a novel protein family involved in timely deactivation and desensitization of signalling via heterotrimeric G proteins.

Authors:  T Wieland; C K Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-07       Impact factor: 3.000

Review 2.  Homer-PIKE complex: a novel link between mGluRI and PI 3-kinase.

Authors:  N Guhan; Bai Lu
Journal:  Trends Neurosci       Date:  2004-11       Impact factor: 13.837

3.  Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.

Authors:  Zafiroula Georgoussi; Leonidas Leontiadis; Georgia Mazarakou; Manolis Merkouris; Karren Hyde; Heidi Hamm
Journal:  Cell Signal       Date:  2005-08-24       Impact factor: 4.315

4.  Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum.

Authors:  X Shi; J F McGinty
Journal:  Neuroscience       Date:  2006-02-03       Impact factor: 3.590

5.  Regulators of G protein signaling: rapid changes in mRNA abundance in response to amphetamine.

Authors:  S A Burchett; M L Volk; M J Bannon; J G Granneman
Journal:  J Neurochem       Date:  1998-05       Impact factor: 5.372

6.  A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning.

Authors:  Bernard Le Foll; Jorge Diaz; Pierre Sokoloff
Journal:  Neuroreport       Date:  2005-02-08       Impact factor: 1.837

7.  Knockout of ERK1 enhances cocaine-evoked immediate early gene expression and behavioral plasticity.

Authors:  Susan M Ferguson; Stefania Fasano; Pengwei Yang; Riccardo Brambilla; Terry E Robinson
Journal:  Neuropsychopharmacology       Date:  2006-01-11       Impact factor: 7.853

8.  BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.

Authors:  O Guillin; J Diaz; P Carroll; N Griffon; J C Schwartz; P Sokoloff
Journal:  Nature       Date:  2001-05-03       Impact factor: 49.962

9.  Regulation of amygdala-dependent learning by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol-3-kinase.

Authors:  Li-Chin Ou; Po-Wu Gean
Journal:  Neuropsychopharmacology       Date:  2006-02       Impact factor: 7.853

10.  Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses.

Authors:  M Xu; R Moratalla; L H Gold; N Hiroi; G F Koob; A M Graybiel; S Tonegawa
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

View more
  34 in total

Review 1.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

2.  The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

Authors:  Reka Natarajan; Bryan K Yamamoto
Journal:  Basal Ganglia       Date:  2011-07-01

3.  Dopamine D1 and N-methyl-D-aspartate receptors and extracellular signal-regulated kinase mediate neuronal morphological changes induced by repeated cocaine administration.

Authors:  Z Ren; W L Sun; H Jiao; D Zhang; H Kong; X Wang; M Xu
Journal:  Neuroscience       Date:  2010-03-23       Impact factor: 3.590

Review 4.  AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future.

Authors:  M Scott Bowers; Billy T Chen; Antonello Bonci
Journal:  Neuron       Date:  2010-07-15       Impact factor: 17.173

5.  Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice.

Authors:  Marjelo A Mines; Richard S Jope
Journal:  Cell Signal       Date:  2012-03-10       Impact factor: 4.315

6.  Differential subcellular distribution of rat brain dopamine receptors and subtype-specific redistribution induced by cocaine.

Authors:  Pamela J Voulalas; John Schetz; Ashiwel S Undieh
Journal:  Mol Cell Neurosci       Date:  2011-01-12       Impact factor: 4.314

7.  Morphine and cocaine increase serum- and glucocorticoid-inducible kinase 1 activity in the ventral tegmental area.

Authors:  Elizabeth A Heller; Sophia Kaska; Barbara Fallon; Deveroux Ferguson; Pamela J Kennedy; Rachael L Neve; Eric J Nestler; Michelle S Mazei-Robison
Journal:  J Neurochem       Date:  2014-08-26       Impact factor: 5.372

8.  RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.

Authors:  Deborah J Luessen; Tyler P Hinshaw; Haiguo Sun; Allyn C Howlett; Glen Marrs; Brian A McCool; Rong Chen
Journal:  Neuropharmacology       Date:  2016-08-12       Impact factor: 5.250

9.  mTORC1 inhibition in the nucleus accumbens 'protects' against the expression of drug seeking and 'relapse' and is associated with reductions in GluA1 AMPAR and CAMKIIα levels.

Authors:  Morgan H James; Rikki K Quinn; Lin Kooi Ong; Emily M Levi; Janine L Charnley; Doug W Smith; Phillip W Dickson; Christopher V Dayas
Journal:  Neuropsychopharmacology       Date:  2014-01-28       Impact factor: 7.853

10.  Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice.

Authors:  Sarah Jane Harrison; José N Nobrega
Journal:  Psychopharmacology (Berl)       Date:  2008-12-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.